Skip to main content

Enrollment in the Health Benefits for Immigrant Adults (HBIA) program will be temporarily paused effective July 1, 2023.

Enrollment in the Health Benefits for Immigrant Seniors (HBIS) program will be temporarily paused effective Nov. 6, 2023.

Elizabeth M. Whitehorn, Director

Drugs and Therapeutics Committee Meeting Results Meeting Results for: December 12, 2007

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Altabax New Drug Appeal Require Prior Approval Prior Approval Required
Avinza PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Azor New Drug Initial Review Require Prior Approval Prior Approval Required
Byetta New Drug Appeal Require Prior Approval Prior Approval Required
Cerefolin NAC New Drug Initial Review Require Prior Approval Prior Approval Required
Depakote ER PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Exforge New Drug Appeal Require Prior Approval Prior Approval Required
Invega New Drug Initial Review Remove Prior Approval Requirement Prior Approval requirement removed
Istalol PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Lantus PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Natelle PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Neupro New Drug Initial Review Remove Prior Approval Requirement Prior Approval requirement removed
Perforomist New Drug Initial Review Require Prior Approval Prior Approval Required
Pylera New Drug Appeal Remove Prior Approval Requirement Prior Approval Required
Veramyst New Drug Appeal Require Prior Approval Prior Approval Required
Xibrom PDL Appeal Remain Non-Preferred Non-Preferred � PDL Class
Xyzal New Drug Initial Review Require Prior Approval Prior Approval Required
Zinotic New Drug Initial Review Require Prior Approval Prior Approval Required
Zyflo CR New Drug Initial Review Require Prior Approval Prior Approval Required